KILITCH DRUGS (INDIA)
|
KILITCH DRUGS (INDIA) Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr |
Equity - Authorised | ₹25 Cr | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
Equity - Issued | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr |
Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹0.35 Cr | ₹5.35 Cr | ₹2.85 Cr | ₹0.35 Cr | ₹1.19 Cr |
Total Reserves | ₹160 Cr | ₹131 Cr | ₹121 Cr | ₹111 Cr | ₹102 Cr |
Securities Premium | ₹47 Cr | ₹38 Cr | ₹38 Cr | ₹38 Cr | ₹38 Cr |
Capital Reserves | ₹0.71 Cr | ₹0.71 Cr | ₹0.71 Cr | ₹0.71 Cr | ₹0.71 Cr |
Profit & Loss Account Balance | ₹84 Cr | ₹70 Cr | ₹59 Cr | ₹52 Cr | ₹48 Cr |
General Reserves | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
Other Reserves | ₹12 Cr | ₹6.19 Cr | ₹6.63 Cr | ₹4.63 Cr | ₹-0.68 Cr |
Reserve excluding Revaluation Reserve | ₹160 Cr | ₹131 Cr | ₹121 Cr | ₹111 Cr | ₹102 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹176 Cr | ₹152 Cr | ₹139 Cr | ₹127 Cr | ₹118 Cr |
Minority Interest | ₹-0.62 Cr | ₹-1.02 Cr | ₹1.21 Cr | ₹2.35 Cr | ₹2.22 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-2.56 Cr | ₹-1.98 Cr | ₹-1.51 Cr | ₹-1.28 Cr | ₹-0.97 Cr |
Deferred Tax Assets | ₹2.56 Cr | ₹1.98 Cr | ₹1.51 Cr | ₹1.28 Cr | ₹0.97 Cr |
Deferred Tax Liability | - | - | - | - | - |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.17 Cr | ₹0.07 Cr | ₹0.28 Cr | ₹0.38 Cr | ₹0.39 Cr |
Total Non-Current Liabilities | ₹-2.39 Cr | ₹-1.91 Cr | ₹-1.24 Cr | ₹-0.90 Cr | ₹-0.58 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹26 Cr | ₹41 Cr | ₹43 Cr | ₹54 Cr | ₹7.10 Cr |
Sundry Creditors | ₹26 Cr | ₹41 Cr | ₹43 Cr | ₹54 Cr | ₹7.10 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹0.28 Cr | ₹0.25 Cr | ₹0.57 Cr | ₹1.41 Cr | ₹1.22 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹0.28 Cr | ₹0.25 Cr | ₹0.57 Cr | ₹1.41 Cr | ₹1.22 Cr |
Short Term Borrowings | ₹32 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr |
Secured ST Loans repayable on Demands | ₹31 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr |
Working Capital Loans- Sec | ₹31 Cr | ₹20 Cr | ₹18 Cr | ₹12 Cr | ₹13 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-31 Cr | ₹-20 Cr | ₹-18 Cr | ₹-12 Cr | ₹-12 Cr |
Short Term Provisions | ₹6.70 Cr | ₹5.56 Cr | ₹5.41 Cr | ₹3.45 Cr | ₹1.04 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.31 Cr | ₹4.04 Cr | ₹4.40 Cr | ₹2.62 Cr | ₹0.16 Cr |
Provision for post retirement benefits | ₹1.25 Cr | ₹1.38 Cr | ₹0.48 Cr | ₹0.46 Cr | ₹0.49 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.14 Cr | ₹0.13 Cr | ₹0.53 Cr | ₹0.37 Cr | ₹0.38 Cr |
Total Current Liabilities | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr | ₹22 Cr |
Total Liabilities | ₹237 Cr | ₹218 Cr | ₹208 Cr | ₹202 Cr | ₹142 Cr |
ASSETS | |||||
Gross Block | ₹112 Cr | ₹111 Cr | ₹108 Cr | ₹71 Cr | ₹71 Cr |
Less: Accumulated Depreciation | ₹50 Cr | ₹47 Cr | ₹44 Cr | ₹41 Cr | ₹39 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹62 Cr | ₹64 Cr | ₹65 Cr | ₹30 Cr | ₹32 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹5.97 Cr | ₹3.62 Cr | ₹3.16 Cr | ₹65 Cr | ₹30 Cr |
Non Current Investments | ₹23 Cr | ₹23 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
Long Term Investment | ₹23 Cr | ₹23 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
Quoted | ₹1.08 Cr | ₹0.94 Cr | ₹1.01 Cr | ₹0.99 Cr | ₹0.85 Cr |
Unquoted | ₹22 Cr | ₹22 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
Long Term Loans & Advances | ₹0.72 Cr | ₹0.62 Cr | ₹0.46 Cr | ₹0.44 Cr | ₹0.36 Cr |
Other Non Current Assets | ₹0.01 Cr | ₹0.02 Cr | ₹2.14 Cr | ₹1.76 Cr | ₹0.54 Cr |
Total Non-Current Assets | ₹92 Cr | ₹91 Cr | ₹94 Cr | ₹122 Cr | ₹86 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹49 Cr | ₹39 Cr | ₹47 Cr | ₹36 Cr | ₹28 Cr |
Quoted | ₹49 Cr | ₹39 Cr | ₹47 Cr | ₹36 Cr | ₹28 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹3.99 Cr | ₹2.05 Cr | ₹5.00 Cr | ₹3.59 Cr | ₹5.56 Cr |
Raw Materials | ₹3.26 Cr | ₹1.43 Cr | ₹4.16 Cr | ₹2.79 Cr | ₹3.67 Cr |
Work-in Progress | ₹0.19 Cr | ₹0.17 Cr | ₹0.40 Cr | ₹0.35 Cr | ₹0.45 Cr |
Finished Goods | ₹0.55 Cr | ₹0.45 Cr | ₹0.45 Cr | ₹0.45 Cr | ₹1.44 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹63 Cr | ₹54 Cr | ₹41 Cr | ₹23 Cr | ₹16 Cr |
Debtors more than Six months | ₹14 Cr | ₹15 Cr | ₹22 Cr | ₹12 Cr | ₹16 Cr |
Debtors Others | ₹58 Cr | ₹46 Cr | ₹23 Cr | ₹14 Cr | ₹2.13 Cr |
Cash and Bank | ₹20 Cr | ₹20 Cr | ₹10 Cr | ₹13 Cr | ₹2.80 Cr |
Cash in hand | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Balances at Bank | ₹20 Cr | ₹20 Cr | ₹10 Cr | ₹12 Cr | ₹2.79 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.71 Cr | ₹0.54 Cr | ₹0.36 Cr | ₹0.05 Cr | ₹0.04 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.03 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.03 Cr |
Prepaid Expenses | ₹0.09 Cr | ₹0.16 Cr | ₹0.05 Cr | ₹0.03 Cr | ₹0.01 Cr |
Other current_assets | ₹1.59 Cr | ₹0.36 Cr | ₹0.29 Cr | - | - |
Short Term Loans and Advances | ₹8.00 Cr | ₹10 Cr | ₹10 Cr | ₹4.91 Cr | ₹3.73 Cr |
Advances recoverable in cash or in kind | ₹5.33 Cr | ₹8.00 Cr | ₹8.37 Cr | ₹1.80 Cr | ₹0.86 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹2.67 Cr | ₹2.36 Cr | ₹1.67 Cr | ₹3.11 Cr | ₹2.87 Cr |
Total Current Assets | ₹146 Cr | ₹126 Cr | ₹114 Cr | ₹80 Cr | ₹56 Cr |
Net Current Assets (Including Current Investments) | ₹82 Cr | ₹58 Cr | ₹45 Cr | ₹7.05 Cr | ₹34 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹237 Cr | ₹218 Cr | ₹208 Cr | ₹202 Cr | ₹142 Cr |
Contingent Liabilities | - | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹5.80 Cr |
Total Debt | ₹32 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr |
Book Value | 109.40 | 93.85 | 87.43 | 81.82 | 75.85 |
Adjusted Book Value | 109.40 | 93.85 | 87.43 | 81.82 | 75.85 |
Compare Balance Sheet of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹523.4 Cr | 0.6% | 5.4% | -8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 0.6% |
5.4% |
-8% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses